Compare Stocks: WELL, VMD, QIPT, and SYN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
QIPT Quipt Home Medical	$3.65	$3.62	$1.35 ▼ $3.65	$162.30M	0.54	676,348 shs	N/A
SYN Synthetic Biologics		$0.00	$0.97 ▼ $4.56	$16.16M	1.38	197,338 shs	57,700 shs
VMD Viemed Healthcare	$9.08	$10.59	$6.05 ▼ $12.61	$345.86M	1.09	417,798 shs	185,583 shs
WELL Welltower	$236.07 0.0%	$237.37	$163.75 ▼ $255.20	$170.15B	0.76	2.68 million shs	2.01 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
QIPT Quipt Home Medical	0.00%	0.00%	0.00%	0.00%	+40.93%
SYN Synthetic Biologics	0.00%	0.00%	0.00%	0.00%	0.00%
VMD Viemed Healthcare	0.00%	+2.95%	-6.68%	-8.47%	+31.98%
WELL Welltower	0.00%	-0.61%	-0.55%	+18.06%	+40.70%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
QIPT Quipt Home Medical	$3.65	$3.62	$1.35 ▼ $3.65	$162.30M	0.54	676,348 shs	N/A
SYN Synthetic Biologics		$0.00	$0.97 ▼ $4.56	$16.16M	1.38	197,338 shs	57,700 shs
VMD Viemed Healthcare	$9.08	$10.59	$6.05 ▼ $12.61	$345.86M	1.09	417,798 shs	185,583 shs
WELL Welltower	$236.07 0.0%	$237.37	$163.75 ▼ $255.20	$170.15B	0.76	2.68 million shs	2.01 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
QIPT Quipt Home Medical	0.00%	0.00%	0.00%	0.00%	+40.93%
SYN Synthetic Biologics	0.00%	0.00%	0.00%	0.00%	0.00%
VMD Viemed Healthcare	0.00%	+2.95%	-6.68%	-8.47%	+31.98%
WELL Welltower	0.00%	-0.61%	-0.55%	+18.06%	+40.70%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
QIPT Quipt Home Medical	1.75	Reduce	$3.65	N/A
SYN Synthetic Biologics	0.00	N/A	N/A	N/A
VMD Viemed Healthcare	2.25	Hold	$14.00	54.19% Upside
WELL Welltower	2.82	Moderate Buy	$251.06	6.35% Upside

Current Analyst Ratings Breakdown

Latest WELL, VMD, QIPT, and SYN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2026	WELL Welltower	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$244.00 ➝ $251.00
9/1/2026	WELL Welltower	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$215.00 ➝ $251.00
9/1/2026	WELL Welltower	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$237.00 ➝ $266.00
8/31/2026	WELL Welltower	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$254.00 ➝ $259.00
8/24/2026	VMD Viemed Healthcare	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$14.00
8/17/2026	VMD Viemed Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
8/5/2026	VMD Viemed Healthcare	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/4/2026	WELL Welltower	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$240.00 ➝ $275.00
8/3/2026	VMD Viemed Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
8/3/2026	WELL Welltower	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$238.00 ➝ $260.00
7/31/2026	WELL Welltower	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$235.00 ➝ $260.00

(Data available from 9/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
QIPT Quipt Home Medical	$264.97M	0.61	$0.95 per share	3.85	$2.58 per share	1.41
SYN Synthetic Biologics	N/A	N/A	N/A	N/A	$4.95 per share	N/A
VMD Viemed Healthcare	$270.28M	1.28	$1.15 per share	7.89	$3.78 per share	2.40
WELL Welltower	$10.84B	15.70	$4.48 per share	52.71	$62.56 per share	3.77

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
QIPT Quipt Home Medical	-$10.70M	-$0.24	N/A	N/A	N/A	-4.05%	-9.94%	-4.10%	N/A
SYN Synthetic Biologics	-$14.27M	-$1.21	N/A	N/A	N/A	N/A	-26.14%	-22.74%	N/A
VMD Viemed Healthcare	$14.93M	$0.36	25.22	18.92	2.24	4.81%	10.16%	7.22%	11/4/2026 (Estimated)
WELL Welltower	$936.84M	$2.18	108.29	31.56	1.13	12.15%	3.56%	2.35%	10/26/2026 (Estimated)

Latest WELL, VMD, QIPT, and SYN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/3/2026	Q2 2026	VMD Viemed Healthcare	$0.12	$0.07	-$0.05	$0.07	$78.00 million	$78.10 million
7/27/2026	Q2 2026	WELL Welltower	$0.66	$0.61	-$0.05	$0.61	$3.40 billion	$3.54 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
QIPT Quipt Home Medical	N/A	N/A	N/A	N/A	N/A
SYN Synthetic Biologics	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	N/A	N/A	N/A	N/A	N/A
WELL Welltower	$3.40	1.44%	+0.87%	155.96%	2 Years

Latest WELL, VMD, QIPT, and SYN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/27/2026	WELL Welltower	quarterly	$0.85	1.48%	8/12/2026	8/12/2026	8/20/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
QIPT Quipt Home Medical	0.81	1.04	0.68
SYN Synthetic Biologics	N/A	4.14	4.14
VMD Viemed Healthcare	0.04	1.13	1.02
WELL Welltower	0.37	3.16	3.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
QIPT Quipt Home Medical	42.85%
SYN Synthetic Biologics	74.38%
VMD Viemed Healthcare	74.24%
WELL Welltower	94.80%

Insider Ownership

Company	Insider Ownership
QIPT Quipt Home Medical	13.40%
SYN Synthetic Biologics	2.15%
VMD Viemed Healthcare	20.60%
WELL Welltower	0.37%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
QIPT Quipt Home Medical	1,600	44.47 million	38.51 million	Optionable
SYN Synthetic Biologics	16	15.84 million	15.50 million	Not Optionable
VMD Viemed Healthcare	1,382	38.09 million	30.24 million	Not Optionable
WELL Welltower	510	720.74 million	718.08 million	Optionable

WELL, VMD, QIPT, and SYN Headlines

Recent News About These Companies

Promising Real Estate Stocks To Research - September 7th

1 hour ago | marketbeat.com

Key Reasons to Add Welltower Stock to Your Portfolio Right Now

4 hours ago | zacks.com

277,967 Shares in Welltower Inc. $WELL Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al

September 7 at 6:07 AM | marketbeat.com

California State Teachers Retirement System Purchases 243,046,172 Shares of Welltower Inc. $WELL

September 7 at 4:08 AM | marketbeat.com

Amundi Boosts Stock Holdings in Welltower Inc. $WELL

September 7 at 3:04 AM | marketbeat.com

Welltower Inc. $WELL Stock Position Increased by Saudi Central Bank

September 6 at 5:51 AM | marketbeat.com

Markowski Investments Takes $1.30 Million Position in Welltower Inc. $WELL

September 5 at 6:08 AM | marketbeat.com

TD Waterhouse Canada Inc. Acquires 6,889 Shares of Welltower Inc. $WELL

September 5 at 5:20 AM | marketbeat.com

Welltower (WELL) Looks Fully Valued On A 4% Premium To Fair Value

September 5 at 1:19 AM | finance.yahoo.com

The Baby Boomers Are Turning 80—3 REITs Built to Cash In

September 4 at 8:08 AM | 247wallst.com

NEOS Investment Management LLC Has $56.33 Million Stock Position in Welltower Inc. $WELL

September 4 at 5:35 AM | marketbeat.com

Real Estate Stocks To Follow Today - September 1st

September 4 at 4:03 AM | americanbankingnews.com

Meet Shankh Mitra, Welltower CEO who earned $821 million in 2025

September 3, 2026 | cnbctv18.comC

Shankh Mitra: How a Jadavpur University Graduate Became One of the World’s Highest-Paid CEOs

September 3, 2026 | careerindia.comC

372,430 Shares in Welltower Inc. $WELL Bought by Nykredit A S

September 3, 2026 | marketbeat.com

Northwestern Mutual Wealth Management Co. Has $15.42 Million Holdings in Welltower Inc. $WELL

September 3, 2026 | marketbeat.com

Top Real Estate Stocks To Watch Today - August 31st

September 3, 2026 | americanbankingnews.com

B. Metzler seel. Sohn & Co. AG Acquires 21,335 Shares of Welltower Inc. $WELL

September 3, 2026 | marketbeat.com

Proficio Capital Partners LLC Invests $1.10 Million in Welltower Inc. $WELL

September 2, 2026 | marketbeat.com

Who is Shankh Mitra? How a Jadavpur University engineer became one of the World's highest-paid CEOs

September 2, 2026 | moneycontrol.com

Meet Shankh Mitra: The Jadavpur University graduate who became one of the world's highest-paid CEOs

September 2, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

WELL, VMD, QIPT, and SYN Company Descriptions

Quipt Home Medical NASDAQ:QIPT

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Synthetic Biologics NYSEAMERICAN:SYN

Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics; SYN-005 for the prevention and treatment of pertussis; and VCN-11 to treat cancer. It has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Synthetic Biologics, Inc. is headquartered in Rockville, Maryland.

Viemed Healthcare NASDAQ:VMD

$9.08 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Welltower NYSE:WELL

$236.07 -0.10 (-0.04%)

As of 09/4/2026 03:58 PM Eastern

Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest WELL, VMD, QIPT, and SYN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest WELL, VMD, QIPT, and SYN Earnings

Compare Dividends

Latest WELL, VMD, QIPT, and SYN Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

WELL, VMD, QIPT, and SYN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

WELL, VMD, QIPT, and SYN Company Descriptions

Quipt Home Medical NASDAQ:QIPT

Synthetic Biologics NYSEAMERICAN:SYN

Viemed Healthcare NASDAQ:VMD

Welltower NYSE:WELL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools